Back to results
US 2026/0028323 A1Published application
Lipid compounds and lipid nanoparticle compositions
AssigneesRinuagene Biotechnology Co., Ltd., Rinuagene International Hk Limited
InventorsShan Cen, Kai Lv, Zhenlei Yu, Yijie Dong
Life of this patent
Estimating the term…
Abstract
The present application disclosed a compound of formula (I) and a salt and a stereoisomer thereof, wherein each variable is as defined in the specification. The present application also disclosed a nanoparticle composition comprising the compound or a salt or a stereoisomer thereof, and the use of the nanoparticle composition for delivering active agents.
Claims31
A compound of formula (I), or a salt or a stereoisomer thereof,
- wherein
- R1 is
- wherein R1a and R1b are independently selected from H and C1-C6 alkyl, and R2 and R3 are independently selected from H and C1-C6 alkyl;
- R4, R5 and R6 are independently selected from C1-C14 alkyl;
- X and Y are independently selected from O and S;
- X1 and X2 are independently selected from C═O and O, and Y1 and Y2 are independently selected from C═O and O, with the proviso that X1 and Y1 are not both C═O or O, and X2 and Y2 are not both C═O or O;
- m and n are independently selected from 0, 1, and 2, with the proviso that m and n are not both 0;
- o and p are independently selected from 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10;
- and
- q is selected from 0, 1, 2, 3, 4, 5, and 6.
7 more elements
(canceled)
10-11. (canceled)
14-15. (canceled)
(canceled)
19-23. (canceled)
(canceled)
28-29. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.